echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Ann Clin Transl Neurol: CXCR4 aortics stimulate the regeneration of axons after sebra nerve damage.

    Ann Clin Transl Neurol: CXCR4 aortics stimulate the regeneration of axons after sebra nerve damage.

    • Last Update: 2020-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The purpose of this study is to test whether the signal axis CXCL12 alpha-CXCR4 is activated after the setan nerve is squeezed/cut, and to test the activity of the new CXCR4 astration nuCC-390 in promoting nerve damage recovery, the results of which were published online in Ann Clin Transl Neurol.
    crush or cut off the sebra nerve.
    the expression and positioning of CXCL12 alpha and CXCR4 through specific antibody imaging.
    their function in neuroregeneration is determined by neutralizer CXCL12 alpha, and CXCR4 specific antagonist AMD3100, using a composite muscle action head (CMAP) as a quantitative reading.
    the activity of NUCC-390 to neurogeneration through imaging and CMAP records.
    results showed that CXCR4 was expressed at the damaged site within the axon, while its lid, CXCL12 alpha, was expressed in Schwan cells.
    CXCL12 alpha-CXCR4 axis is involved in the recovery of nerve transmission in injured nerves.
    , the small molecule NUCC-390 strongly promotes nerve function and anatomical recovery by acting very similarly to CXCL12 alpha.
    this pharmacological effect is due to nuCC-390 in vitro and in vivo can promote the elongation of motor neuron axons.
    , imaging and electrophysiological data provide new and compelling evidence that the CXCL12 alpha-CXCR4 axis is involved in seth nerve repair after crushing/cutting.
    makes NUCC-390 a strong candidate molecule that stimulates nerve repair by promoting axon elongation.
    the molecule in other neuron damage models to lay the foundation for clinical trials of NUCC-390 in the repair of nerves around the human body.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.